GPCR News
Reflections on My PhD Journey: Lessons Learned
Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Profiling Immune Cell and Platelet Transcriptomes
Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking
Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
Do You Believe AI Could Accelerate Drug Discovery?
Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
Canonical chemokine receptors as scavenging “decoys”
Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
Dynamic GPCR activation revealed through time-resolved Cryo-EM
Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
From DNA day to GPCR genomics
GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
An overview of the compartmentalized GPCR Signaling: Relevance and Implications
Chemokine receptor-targeted drug discovery: progress and challenges